A doctor walks through four of the most talked about weight loss drugs in one overview, covering the big names people ask about most.
Recap by typeshit. Full story at Doctor Michael Mueller.
A sponsored-style explainer that walks through semaglutide versus tirzepatide and the post-shortage compounding limits, while featuring telehealth company Mochi Health.
Good Morning America looks at GLP-1 use spreading from adults to a growing number of teens being treated for obesity.
ABC News' chief medical correspondent walks through the latest Novo Nordisk GLP-1 medication and what sets it apart from drugs already on the market.
Investseekers shares notes on the upcoming French rollout of the Wegovy pill and where Novo Nordisk might launch it next in Europe.
An older explainer sorting the weight loss market into approved medications, telehealth compounded drugs, online gray market peptides and supplements.
A short social clip runs through the daily checklist of a GLP-1 routine: injections, water, protein and keeping tabs on progress.
Loading…